| Accession | Acc. Gene-, Name | Start | End | Subsequence | Logic | PDB | Organism | Length |
|---|---|---|---|---|---|---|---|---|
| ELMI000583 | P48023 FASLG TNFL6_HUMAN |
249 | 254 | SSYLGAVFNLTSADHLYVNV | TP | --- | Homo sapiens (Human) | 281 |
Instance evidence
| Evidence class | PSI-MI | Method | BioSource | PubMed | Logic | Reliability | Notes |
|---|---|---|---|---|---|---|---|
| not annotated | not specified | Orlinick,1997 | not specified | not specified |
Pathways
- African trypanosomiasis
- Allograft rejection
- Apoptosis
- Autoimmune thyroid disease
- Chagas disease
- Cytokine cytokine receptor interaction
- FoxO signaling pathway
- Graft versus host disease
- Hepatitis B
- Hepatitis C
- Herpes simplex virus 1 infection
- Human cytomegalovirus infection
- Human immunodeficiency virus 1 infection
- Human papillomavirus infection
- Influenza A
- Lipid and atherosclerosis
- MAPK signaling pathway
- Measles
- Natural killer cell mediated cytotoxicity
- Necroptosis
- Neurotrophin signaling pathway
- Non alcoholic fatty liver disease
- PI3K Akt signaling pathway
- Pathogenic Escherichia coli infection
- Pathways in cancer
- Pathways of neurodegeneration multiple diseases
- Platinum drug resistance
- Proteoglycans in cancer
- Ras signaling pathway
- Type I diabetes mellitus
Please cite:
The Eukaryotic Linear Motif resource: 2022 release.
(PMID:34718738)
ELM data can be downloaded & distributed for non-commercial use according to the ELM Software License Agreement
ELM data can be downloaded & distributed for non-commercial use according to the ELM Software License Agreement